UBS Group
LFSC

UBS Group’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

UBS Group’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$735 Sell
21
-324
-94% -$11.5K ﹤0.01% 9768
2025
Q4 		$12.6K Buy
+345
New +$11.8K ﹤0.01% 8100
2025
Q3 		– Sell
-853
Closed -$21K – 11210
2025
Q2 		$21K Buy
853
+845
+10,563% +$19.3K ﹤0.01% 8394
2025
Q1 		$180 Buy
+8
New +$195 ﹤0.01% 9898

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
CCWP
Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group's LFSC Position: Q1 2026 in Review

UBS Group reduced its F/m Emerald Life Sciences Innovation ETF (LFSC) stake by 94% in Q1 2026, selling an estimated $11.5K and leaving 21 shares worth $735. The position accounts for ﹤0.01% of the portfolio, ranked #9768.

UBS Group first reported a position in LFSC in Q1 2025 and has held it in 4 quarters since. The position peaked at $21K in Q2 2025. 7 funds tracked by Wall St. Rank hold LFSC as of Q1 2026.

  • UBS Group held 21 shares of F/m Emerald Life Sciences Innovation ETF worth $735 as of Q1 2026.
  • UBS Group sold 324 F/m Emerald Life Sciences Innovation ETF shares in Q1 2026, an estimated $11.5K.
  • F/m Emerald Life Sciences Innovation ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9768 holding.
  • UBS Group first reported a position in F/m Emerald Life Sciences Innovation ETF in Q1 2025 and has held it in 4 quarters since.
  • UBS Group's F/m Emerald Life Sciences Innovation ETF position peaked at $21K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.